The principal goal of the proposed Center for Targeted Therapeutics (CTT), a Center of Biomedical Research Excellence (COBRE) at the University of South Carolina (USC), is to attract and foster the professional development of talented junior scientists, who are motivated to make a difference in the treatment of serious diseases. The CTT will be located at the SC College of Pharmacy (SCCP) at the University of South Carolina (USC) and the Medical University of South Carolina (MUSC), with one of the target faculty at the USC School of Medicine (SOM). The Center operations include four research projects led by four target junior faculty members (two at USC-SCCP, one at MUSC-SCCP and one at USC-SOM), with expertise in functional genomics, drug discovery, neuroscience and nanoparticle drug delivery. The Program will also include three resource cores: the Functional Genomics Core (USC-SCCP), the Synthetic Chemistry and Drug Discovery Core (MUSC-SCCP) and the Microscopy and Flow Cytometry Core (USCSCCP), each managed by a Director and a co-Director, who will provide scientific and intellectual advice in project development, along with technological support. Each of the projects will be working with each of the cores, except that one project, based at MUSC, will not utilize the Microscopy and Flow Cytometry core at USC. The CTT will take advantage of the existing integration between USC and MUSC in the South Carolina College of Pharmacy, which is in the unique position of being shared between the two Universities, with strong components on both campuses, and a well-developed system of video communication that allows for seamless communication and sharing of teaching and research programs. The CTT will be well-positioned to take full advantage of the resources of both institutions, where drug discovery and translational research are strong priorities, and also interface with IDeA programs already in place. The CTT umbrella will encompass several scientific areas critical for targeted therapeutics and spanning multiple diseases among which are cancer and neurologic disorders that are particularly relevant to the South Carolina population.

Public Health Relevance

The proposed COBRE Center for Targeted Therapeutics will leverage the resources two institutions (USC and MUSC) already linked by multiple common initiatives and programs, to promote the development of junior faculty and accelerate the rational, targeted discovery and application of new drugs for cancer, neurological disorders and other diseases of strong public interest and relevance

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
1P20GM109091-01
Application #
8625915
Study Section
Special Emphasis Panel (ZGM1-TWD-A (C1))
Program Officer
Zlotnik, Hinda
Project Start
2014-07-10
Project End
2019-04-30
Budget Start
2014-07-10
Budget End
2015-04-30
Support Year
1
Fiscal Year
2014
Total Cost
$2,535,340
Indirect Cost
$594,345
Name
University of South Carolina at Columbia
Department
Type
Schools of Pharmacy
DUNS #
041387846
City
Columbia
State
SC
Country
United States
Zip Code
29208
Liang, Jiaxin; Chen, Mengqian; Hughes, Daniel et al. (2018) CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases. Cancer Res 78:6594-6606
Chukwurah, Evelyn; Patel, Rekha C (2018) Stress-induced TRBP phosphorylation enhances its interaction with PKR to regulate cellular survival. Sci Rep 8:1020
Singh, Priyanka; Jenkins, Laura M; Horst, Ben et al. (2018) Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis. Cancer Res 78:2978-2989
Wyatt, Michael D; Reilly, Nicole M; Patel, Shikha et al. (2018) Thiopurine-induced mitotic catastrophe in Rad51d-deficient mammalian cells. Environ Mol Mutagen 59:38-48
Serrao, Anne; Jenkins, Laura M; Chumanevich, Alexander A et al. (2018) Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer. Oncogene 37:4792-4808
Varadaraj, Archana; Magdaleno, Carina; Mythreye, Karthikeyan (2018) Deoxycholate Fractionation of Fibronectin (FN) and Biotinylation Assay to Measure Recycled FN Fibrils in Epithelial Cells. Bio Protoc 8:
Liu, Changlong; Banister, Carolyn E; Weige, Charles C et al. (2018) PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids. Proc Natl Acad Sci U S A 115:E5066-E5075
Yu, Jin; Zhu, Hong; Taheri, Saeid et al. (2018) Impact of nutrition on inflammation, tauopathy, and behavioral outcomes from chronic traumatic encephalopathy. J Neuroinflammation 15:277
Jenkins, Laura M; Horst, Ben; Lancaster, Carly L et al. (2018) Dually modified transmembrane proteoglycans in development and disease. Cytokine Growth Factor Rev 39:124-136
Alam, Amer; K√ľng, Raphael; Kowal, Julia et al. (2018) Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1. Proc Natl Acad Sci U S A 115:E1973-E1982

Showing the most recent 10 out of 49 publications